Based on the key indicators related to Im Cannabis' liquidity, profitability, solvency, and operating efficiency, Im Cannabis Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in October. At present, Im Cannabis' Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 34.4 M, whereas Total Assets are forecasted to decline to about 28 M. Key indicators impacting Im Cannabis' financial strength include:
The financial analysis of Im Cannabis is a critical element in measuring its lifeblood. Investors should not minimize Im Cannabis' ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income
(9.02 Million)
IMCC
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Average Inventory
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Average Receivables
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Stock Based Compensation
Change To Inventory
Investments
Net Borrowings
Total Cashflows From Investing Activities
Change To Account Receivables
Change To Operating Activities
Change To Netincome
Change To Liabilities
Issuance Of Capital Stock
Common Stock Shares Outstanding
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Short Term Investments
Short Long Term Debt Total
Short Term Debt
Net Invested Capital
Short Long Term Debt
Net Working Capital
Other Liab
Net Tangible Assets
Common Stock Total Equity
Common Stock
Property Plant Equipment
Other Assets
Capital Stock
Intangible Assets
Good Will
Capital Lease Obligations
Long Term Investments
Current Deferred Revenue
Depreciation And Amortization
Interest Expense
Total Revenue
Gross Profit
Operating Income
Ebit
Ebitda
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Other Operating Expenses
Total Operating Expenses
Selling General Administrative
Selling And Marketing Expenses
Research Development
Tax Provision
Net Interest Income
Net Income From Continuing Ops
Reconciled Depreciation
Net Income Applicable To Common Shares
Minority Interest
Cost Of Revenue
Interest Income
Probability Of Bankruptcy
Understanding current and past Im Cannabis Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Im Cannabis' financial statements are interrelated, with each one affecting the others. For example, an increase in Im Cannabis' assets may result in an increase in income on the income statement.
Please note, the presentation of Im Cannabis' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Im Cannabis' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Im Cannabis' management manipulating its earnings.
Im Cannabis Stock Summary
Im Cannabis competes with Biofrontera, Universe Pharmaceuticals, Qilian International, Raphael Pharmaceutical, and Ascend Wellness. IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. The company serves medical patients and adult-use recreational consumers. IM Cannabis is traded on NASDAQ Exchange in the United States.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Im Cannabis' financial ratios allow both analysts and investors to convert raw data from Im Cannabis' financial statements into concise, actionable information that can be used to evaluate the performance of Im Cannabis over time and compare it to other companies across industries.
Comparative valuation techniques use various fundamental indicators to help in determining Im Cannabis's current stock value. Our valuation model uses many indicators to compare Im Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Im Cannabis competition to find correlations between indicators driving Im Cannabis's intrinsic value. More Info.
Im Cannabis Corp is rated below average in return on equity category among its peers. It is rated fourth overall in return on asset category among its peers . At present, Im Cannabis' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Im Cannabis' earnings, one of the primary drivers of an investment's value.
Im Cannabis Corp Systematic Risk
Im Cannabis' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Im Cannabis volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Im Cannabis Corp correlated with the market. If Beta is less than 0 Im Cannabis generally moves in the opposite direction as compared to the market. If Im Cannabis Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Im Cannabis Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Im Cannabis is generally in the same direction as the market. If Beta > 1 Im Cannabis moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Im Cannabis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Im Cannabis' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Im Cannabis growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.0486
At present, Im Cannabis' Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
Im Cannabis September 20, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Im Cannabis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Im Cannabis Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Im Cannabis Corp based on widely used predictive technical indicators. In general, we focus on analyzing IMCC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Im Cannabis's daily price indicators and compare them against related drivers.
When running Im Cannabis' price analysis, check to measure Im Cannabis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Im Cannabis is operating at the current time. Most of Im Cannabis' value examination focuses on studying past and present price action to predict the probability of Im Cannabis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Im Cannabis' price. Additionally, you may evaluate how the addition of Im Cannabis to your portfolios can decrease your overall portfolio volatility.